DYNEX CAPITAL INC
No enriched coverage for $DX in the last 7 days.
No SEC Form 4 filings for $DX in the last 30 days.
DYNEX CAPITAL INC (DX) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 4 exhibit101amendmentno10tod.htm EX-10.1 Document Exhibit 10.1 DYNEX CAPITAL, INC. AMENDMENT NO. 10 TO DISTRIBUTION AGREEMENT July 28, 2026 BTIG, LLC 65 East 55 th Street New York, NY 10022 Citizens JMP Securities, LLC 101 California Street Suite 1700 San Francisco, CA 94
Dynex Capital Inc (DX) reported Q2 2026 results for the quarter ended June 30, 2026. Interest income was $302.8M, up from $111.7M a year earlier. Net income was $180.8M, versus a net loss in Q2 2025, and diluted EPS was $0.80. The company attributed results to higher Agency RMBS deployment and active hedging.
Dynex Capital reported Q2 net income to common shareholders of $178.4M, above the S&P Capital IQ consensus of $65.8M, and earnings available for distribution of 36 cents per share vs 34 cents. The REIT said it has increased specified mortgage-backed securities pools aimed at prepayment resistance amid potential AI-driven refinancing risk. Shares traded near $13.17 after a 1.2% drop.
Recent DX coverage spans financial news, earnings and corporate actions.
The amendment expands the authorized share issuance capacity under the distribution agreement, which can increase dilution over time if shares are sold.
Q2 results show a sharp YoY jump in interest income and profitability, with hedging cited as stabilizing book value.
The article frames Dynex’s portfolio construction as a hedge against rising prepayment risk, with management emphasizing resilience across scenarios.
Q2 book value growth, higher liquidity, and reduced leverage support the REIT’s risk profile, while the ATM raise signals continued portfolio expansion.
The restored payout is portrayed as not covered by current EAD, making another trim plausible.
alphai scores every news story that mentions DX with an AI model for sentiment and relevance, and aggregates insider trades from DYNEX CAPITAL INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
DYNEX CAPITAL INC (DX) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 4 exhibit101amendmentno10tod.htm EX-10.1 Document Exhibit 10.1 DYNEX CAPITAL, INC. AMENDMENT NO. 10 TO DISTRIBUTION AGREEMENT July 28, 2026 BTIG, LLC 65 East 55 th Street New York, NY 10022 Citizens JMP Securities, LLC 101 California Street Suite 1700 San Francisco, CA 94
2 min readDynex Capital Inc (DX) reported Q2 2026 results for the quarter ended June 30, 2026. Interest income was $302.8M, up from $111.7M a year earlier. Net income was $180.8M, versus a net loss in Q2 2025, and diluted EPS was $0.80. The company attributed results to higher Agency RMBS deployment and active hedging.
1 min readDynex Capital reported Q2 net income to common shareholders of $178.4M, above the S&P Capital IQ consensus of $65.8M, and earnings available for distribution of 36 cents per share vs 34 cents. The REIT said it has increased specified mortgage-backed securities pools aimed at prepayment resistance amid potential AI-driven refinancing risk. Shares traded near $13.17 after a 1.2% drop.
6 min readDYNEX CAPITAL INC (DX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a2q26earningsrelease.htm EX-99.1 Document Exhibit 99.1 DYNEX CAPITAL, INC. ANNOUNCES SECOND QUARTER 2026 RESULTS GLEN ALLEN, Va . -- Dynex Capital, Inc. (NYSE: DX; "Dynex" or the "Company"), a REIT with a long track record of generating dividends from high-quality mortg
6 min readThe article argues that five mortgage REITs with 10%+ dividend yields face elevated dividend risk. It cites dividend cuts or weak coverage for MFA, DX, ARR, ABR, and ORC, including distributable earnings below dividends, falling book value, and high leverage. It also notes negative total economic returns for all five in Q1 2026.
7 min readDYNEX CAPITAL INC (DX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. dx-20260615 0000826675 FALSE 0000826675 2026-06-15 2026-06-15 0000826675 us-gaap:CommonStockMember 2026-06-15 2026-06-15 0000826675 us-gaap:SeriesCPreferredStockMember 2026-06-15 2026-06-15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________ FORM 8
2 min readDynex Capital (DX) reported Q1 2026 earnings that missed EPS expectations but also announced a new share repurchase program. The stock's current P/E ratio of 12.5x makes it appear more expensive than peers but cheaper than the broader US market, with mixed signals from valuation models. While strong recent earnings growth justifies a higher P/E, a discounted cash flow model suggests the stock is overvalued, presenting conflicting signals for investors.
3 min readThis article analyzes Dynex Capital (DX) valuation after a strong year for its share price. Using two valuation methods, Excess Returns and Price vs Earnings, the article suggests DX may be overvalued by 138.8% per the Excess Returns model but undervalued per the Price vs Earnings model when compared to its proprietary Fair Ratio. Investors are encouraged to consider different narratives for the company's future earnings and risk to determine their own fair value.
4 min readDynex Capital (DX) recently declared common and preferred dividends. The stock trades at a P/E of 8.1x, suggesting it's undervalued compared to the market and peers, despite recent share price declines and revenue contraction. However, a Discounted Cash Flow (DCF) model indicates the stock is overvalued, presenting mixed signals for investors regarding its true valuation.
3 min readDynex Capital, Inc. has announced that it will maintain its monthly dividend at $0.17 per share. This dividend is payable on April 1 to shareholders of record as of March 23. The company, a mortgage real estate investment trust (REIT), aims to provide attractive risk-adjusted returns to its shareholders through regular dividends and capital appreciation of its investments.
2 min read
